Responses
Clinical and epidemiological research
Concise report
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study
Compose a Response to This Article
Other responses
No responses have been published for this article.